Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ILMN
TEVA
Add up to 3 more stocks
ILMN
Illumina, Inc.
+2.75%
$273.04+7.32Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$41.31B
52W Range
$88.00 - $280.17
TEVA
Teva Pharmaceutical Industries Limited
+0.56%
$39.53+0.22Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$46.04B
52W Range
$18.83 - $40.79
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 50.94 | 65.88 |
| Forward P/E | 51.00 | 20.04 |
| PEG Ratio | 11.99 | N/A |
| P/B Ratio | 14.56 | 5.94 |
| P/S Ratio | 9.19 | 2.66 |
| P/FCF Ratio | 43.99 | 34.15 |
| EV/EBITDA | 35.22 | 19.94 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 66.8% | 52.5% |
| Operating Margin | 21.0% | 11.4% |
| Net Margin | 18.4% | 4.1% |
| ROE | 29.1% | 9.1% |
| ROA | 12.4% | 1.8% |
| ROIC | 13.7% | 6.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.80 | 0.88 |
| Quick Ratio | 1.40 | 0.67 |
| Debt/Equity | 0.89 | 2.18 |
| Interest Coverage | 8.55 | 2.35 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.